Animal toxicology studies have not revealed significant adverse effects at therapeutic dose ranges
The assumption driving this overlap: glutathione's role in cellular detoxification must somehow accelerate or protect against the metabolic shifts GLP-1 medications trigger
Mitochondrial Biogenesis: The MOTS-c Revolution The mitochondria are no longer viewed simply as "powerhouses" but as signalling hubs that dictate the fate of the cell
Baseline IGF-1 level and age are the strongest predictors of magnitude
Prebiotics may serve as an alternative treatment as they provide the metabolizable substrates for growth of specific bacteria and hence can alter the microbiota
Introduction Tuberculosis (TB) is a chronic infectious disease caused by an obligate pathogen, Mycobacterium tuberculosis (Mtb), in humans ( in vitro drug resistance to not only INH and RIF, but also all fluoroquinolones and at least one injectable aminoglycoside ( The presence of a mycobacterial population with more than one bacterial phenotype has been observed in patients with TB, as indicated by bacterial populations with varying growth dynamics in sputum samples ( Mycobacterial Persisters Adapt to Stresses in the Host and Exhibit Antibiotic Tolerance Antibiotic Tolerance Host-related stresses, such as hypoxia, acidic conditions, nutrient starvation, oxidative stress, and cytokine responses, alter the metabolic state of pathogens and eventually induces a drug-tolerant phenotype termed persister ( The mechanism of antibiotic tolerance through the formation of persisters in response to a variety of stresses, including nutrient deprivation, oxidative stress, acidic environment, osmotic conditions, and host immune-mediated stresses, has been described in many pathogenic bacteria, including Escherichia coli , Staphylococcus aureus , Pseudomonas aeruginosa , and Mtb ( Mtb Adapts to Host-Mediated Stresses Through Metabolic Regulation Regulation of Transcription Factors Mtb encounters various stresses, such as acidic pH, oxidative stress, hypoxia, nutrient deprivation, and cytokine-mediated effectors, during infection
